Cargando…
The Differential Expression of EphB2 and EphB4 Receptor Kinases in Normal Bladder and in Transitional Cell Carcinoma of the Bladder
Effective treatment of transitional cell carcinoma (TCC) of the bladder requires early diagnosis. Identifying novel molecular markers in TCC would guide the development of diagnostic and therapeutic targets. Ephrins mediate signals via tyrosine kinase activity that modulates diverse physiologic and...
Autores principales: | Li, Xiuqing, Choi, Wesley W., Yan, Rui, Yu, Haiyang, Krasnoperov, Valery, Kumar, S. Ram, Schuckman, Anne, Klumpp, David J., Pan, Chong-Xian, Quinn, David, Gill, Inderbir S., Gill, Parkash S., Liu, Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141800/ https://www.ncbi.nlm.nih.gov/pubmed/25148033 http://dx.doi.org/10.1371/journal.pone.0105326 |
Ejemplares similares
-
EphB4 as a therapeutic target in mesothelioma
por: Liu, Ren, et al.
Publicado: (2013) -
Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
por: Lee, Tae Ho, et al.
Publicado: (2021) -
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
por: Randolph, Matthew E., et al.
Publicado: (2017) -
Reelin induces EphB activation
por: Bouché, Elisabeth, et al.
Publicado: (2013) -
The Roles of EphB2 in Cancer
por: Liu, Wei, et al.
Publicado: (2022)